Liver-Chip Predicts Human Toxicity that was Undetected in Animal Studies for Drugs Halted in Clinical Trials
The goal is that this will ultimately lead to the advancement of better and safer medicines for the benefit of patients.
- The goal is that this will ultimately lead to the advancement of better and safer medicines for the benefit of patients.
- In addition, the chip supports hepatocyte and liver sinusoidal endothelial cell interface, along with relevant cytoarchitecture, and physiological flow.
- Now commercially-available, the Liver-Chip can perform testing across a broad range of applications, including general toxicity, mechanistic toxicity, and nutrient metabolism studies.
- Emulate, Inc. is a privately held company that creates living products for understanding how diseases, medicines, chemicals, and foods affect human health.